Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Neonatal levels of cytokines and risk of autism spectrum disorders: an exploratory register-based historic birth cohort study utilizing the Danish Newborn Screening Biobank.

Abdallah MW, Larsen N, Mortensen EL, Atladóttir HÓ, Nørgaard-Pedersen B, Bonefeld-Jørgensen EC, Grove J, Hougaard DM.

J Neuroimmunol. 2012 Nov 15;252(1-2):75-82. doi: 10.1016/j.jneuroim.2012.07.013. Epub 2012 Aug 20.

PMID:
22917523
2.

Neonatal chemokine levels and risk of autism spectrum disorders: findings from a Danish historic birth cohort follow-up study.

Abdallah MW, Larsen N, Grove J, Bonefeld-Jørgensen EC, Nørgaard-Pedersen B, Hougaard DM, Mortensen EL.

Cytokine. 2013 Feb;61(2):370-6. doi: 10.1016/j.cyto.2012.11.015. Epub 2012 Dec 23.

PMID:
23267761
3.

Amniotic fluid inflammatory cytokines: potential markers of immunologic dysfunction in autism spectrum disorders.

Abdallah MW, Larsen N, Grove J, Nørgaard-Pedersen B, Thorsen P, Mortensen EL, Hougaard DM.

World J Biol Psychiatry. 2013 Sep;14(7):528-38. doi: 10.3109/15622975.2011.639803. Epub 2011 Dec 19.

PMID:
22175527
4.

Neonatal levels of neurotrophic factors and risk of autism spectrum disorders.

Abdallah MW, Mortensen EL, Greaves-Lord K, Larsen N, Bonefeld-Jørgensen EC, Nørgaard-Pedersen B, Hougaard DM, Grove J.

Acta Psychiatr Scand. 2013 Jul;128(1):61-9. doi: 10.1111/acps.12020. Epub 2012 Oct 5.

PMID:
23039165
5.

Amniotic fluid chemokines and autism spectrum disorders: an exploratory study utilizing a Danish Historic Birth Cohort.

Abdallah MW, Larsen N, Grove J, Nørgaard-Pedersen B, Thorsen P, Mortensen EL, Hougaard DM.

Brain Behav Immun. 2012 Jan;26(1):170-6. doi: 10.1016/j.bbi.2011.09.003. Epub 2011 Sep 10.

PMID:
21933705
6.

Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study.

Zerbo O, Yoshida C, Grether JK, Van de Water J, Ashwood P, Delorenze GN, Hansen RL, Kharrazi M, Croen LA.

J Neuroinflammation. 2014 Jun 20;11:113. doi: 10.1186/1742-2094-11-113.

8.

Amniotic fluid MMP-9 and neurotrophins in autism spectrum disorders: an exploratory study.

Abdallah MW, Pearce BD, Larsen N, Greaves-Lord K, Nørgaard-Pedersen B, Hougaard DM, Mortensen EL, Grove J.

Autism Res. 2012 Dec;5(6):428-33. doi: 10.1002/aur.1254. Epub 2012 Sep 24.

PMID:
23008271
9.

Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders.

Suzuki K, Matsuzaki H, Iwata K, Kameno Y, Shimmura C, Kawai S, Yoshihara Y, Wakuda T, Takebayashi K, Takagai S, Matsumoto K, Tsuchiya KJ, Iwata Y, Nakamura K, Tsujii M, Sugiyama T, Mori N.

PLoS One. 2011;6(5):e20470. doi: 10.1371/journal.pone.0020470. Epub 2011 May 27.

10.

Finnish Prenatal Study of Autism and Autism Spectrum Disorders (FIPS-A): overview and design.

Lampi KM, Banerjee PN, Gissler M, Hinkka-Yli-Salomäki S, Huttunen J, Kulmala U, Lindroos J, Niemelä S, Rihko M, Ristkari T, Saanakorpi K, Sarlin T, Sillanmäki L, McKeague IW, Surcel HM, Helenius H, Brown AS, Sourander A.

J Autism Dev Disord. 2011 Aug;41(8):1090-6. doi: 10.1007/s10803-010-1132-6.

PMID:
21082229
11.

Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J.

Brain Behav Immun. 2011 Jan;25(1):40-5. doi: 10.1016/j.bbi.2010.08.003. Epub 2010 Aug 10.

12.

Infections during pregnancy and after birth, and the risk of autism spectrum disorders: a register-based study utilizing a Danish historic birth cohort.

Abdallah MW, Hougaard DM, Nørgaard-Pedersen B, Grove J, Bonefeld-Jørgensen EC, Mortensen EL.

Turk Psikiyatri Derg. 2012 Winter;23(4):229-35.

13.

Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder.

Napolioni V, Ober-Reynolds B, Szelinger S, Corneveaux JJ, Pawlowski T, Ober-Reynolds S, Kirwan J, Persico AM, Melmed RD, Craig DW, Smith CJ, Huentelman MJ.

J Neuroinflammation. 2013 Mar 14;10:38. doi: 10.1186/1742-2094-10-38.

14.

Potential cytokine biomarkers in autism spectrum disorders.

Rose D, Ashwood P.

Biomark Med. 2014;8(9):1171-81. doi: 10.2217/bmm.14.39. Review.

PMID:
25402586
15.

Autism spectrum disorders and maternal serum α-fetoprotein levels during pregnancy.

Abdallah MW, Grove J, Hougaard DM, Nørgaard-Pedersen B, Ibrahimov F, Mortensen EL.

Can J Psychiatry. 2011 Dec;56(12):727-34.

PMID:
22152641
16.

Patterns of contact with hospital for children with an autism spectrum disorder: a Danish register-based study.

Atladóttir HO, Schendel DE, Lauritsen MB, Henriksen TB, Parner ET.

J Autism Dev Disord. 2012 Aug;42(8):1717-28. doi: 10.1007/s10803-011-1416-5.

PMID:
22160299
17.
18.

Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study.

Atladóttir HÓ, Henriksen TB, Schendel DE, Parner ET.

Pediatrics. 2012 Dec;130(6):e1447-54. doi: 10.1542/peds.2012-1107. Epub 2012 Nov 12.

19.

Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology.

Skogstrand K, Thorsen P, Nørgaard-Pedersen B, Schendel DE, Sørensen LC, Hougaard DM.

Clin Chem. 2005 Oct;51(10):1854-66. Epub 2005 Aug 4.

20.

Effects of familial risk factors and place of birth on the risk of autism: a nationwide register-based study.

Lauritsen MB, Pedersen CB, Mortensen PB.

J Child Psychol Psychiatry. 2005 Sep;46(9):963-71.

PMID:
16108999
Items per page

Supplemental Content

Write to the Help Desk